Thymoquinone and TRAIL synergistically reduced the levels of XIAP (X-linked inhibitor of apoptosis), c-FLIP, BCL-2, cIAP1, and cIAP2 in HepG2 cancer cells [71]. Here, TNFSF10 is linked to cancer.